Prosecution Insights
Prosecution Insights
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 2 (40%) |
| §112 only | 1 (20%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NG, JONATHAN K | 1 | 35.8% | +13.4% |
| XU, JUSTIN | 1 | 59.6% | +36.7% |
| AEDER, SEAN E | 1 | 56.9% | +19.9% |
| CHANDRAKUMAR, NIZAL S | 1 | 72.7% | +18.3% |
| LU, CHENG | 1 | 53.7% | +66.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18018807 | PHARMACEUTICAL COMPOSITION COMPRISING CELL EXPRESSING CHIMERIC RECEPTOR | AEDER, SEAN E | 23d overdue |
| 19134024 | ASTHMATIC DISEASE CONDITION ESTIMATION SERVER, ASTHMATIC DISEASE CONDITION ESTIMATION PROGRAM, AND ASTHMATIC DISEASE CONDITION ESTIMATION METHOD | NG, JONATHAN K | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17939198 | THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDERS | CHANDRAKUMAR, NIZAL S | 49d overdue |
| 18018807 | PHARMACEUTICAL COMPOSITION COMPRISING CELL EXPRESSING CHIMERIC RECEPTOR | AEDER, SEAN E | 23d overdue |
| 19134024 | ASTHMATIC DISEASE CONDITION ESTIMATION SERVER, ASTHMATIC DISEASE CONDITION ESTIMATION PROGRAM, AND ASTHMATIC DISEASE CONDITION ESTIMATION METHOD | NG, JONATHAN K | — |
| 18876950 | MANUAL MUSCLE STRENGTH TESTING DEVICE | XU, JUSTIN | — |
| 17603821 | CHIMERIC RECEPTOR THAT RECOGNIZES ENGINEERED SITE IN ANTIBODY | LU, CHENG | — |
| Art Unit | Apps |
|---|---|
| 1642 | 2 |
| 3619 | 1 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19134024 | ASTHMATIC DISEASE CONDITION ESTIMATION SERVER, ASTHMATIC DISEASE CONDITION ESTIMATION PROGRAM, AND ASTHMATIC DISEASE CONDITION ESTIMATION METHOD | NG, JONATHAN K | 3619 | §101§103§112 | Non-Final OA | — | Pending | May 29, 2025 |
| 18876950 | MANUAL MUSCLE STRENGTH TESTING DEVICE | XU, JUSTIN | — | §103 | Non-Final OA | — | Pending | Dec 19, 2024 |
| 18018807 | PHARMACEUTICAL COMPOSITION COMPRISING CELL EXPRESSING CHIMERIC RECEPTOR | AEDER, SEAN E | 1642 | §102§103§112 | Non-Final OA | 23d overdue | Pending | Jan 30, 2023 |
| 17939198 | THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDERS | CHANDRAKUMAR, NIZAL S | 1625 | §103 | Final Rejection | 49d overdue | Pending | Sep 07, 2022 |
| 17603821 | CHIMERIC RECEPTOR THAT RECOGNIZES ENGINEERED SITE IN ANTIBODY | LU, CHENG | 1642 | §112 | Non-Final OA | — | Pending | Oct 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial